Literature DB >> 3008795

Parathyroid hormone-stimulated development of osteoclasts in cultures of cells from neonatal murine calvaria.

R L Jilka.   

Abstract

Evidence was sought for the presence of osteoclasts or preosteoclasts in cells prepared from neonatal murine calvaria by sequential enzymatic digestion. Freshly isolated cells released late in the digestion process resorbed both living and devitalized calvarial bone matrix in response to PTH, accompanied by the development of osteoclasts. Light and scanning electron microscopy of these cells after 1 to 2 days in culture revealed the presence of round cells (10 to 15 mu in diameter) with minimal surface microvilli in addition to the larger osteoblastic cells. Few cells contained tartrate-resistant acid phosphatase (TRAPase). If initially seeded at confluent density, more cells positive for TRAPase developed during subsequent culture, and these cells retained the ability to resorb calvarial bone matrix upon treatment with parathyroid hormone (PTH). These cultured cells responded to PTH with increased secretion of TRAPase into the medium and increased numbers of TRAPase positive cells. These were 20 to 50 mu in diameter, sometimes multinucleated, and some were spread 100 to 200 mu in length. Observations of living cells that took up neutral red showed that, upon treatment with calcitonin (CT), surface filopodia of some but not all of the labeled cells retracted within 30 minutes. Loss of resorptive response to PTH, as well as PTH-stimulated development of TRAPase-positive cells, occurred if the cells were initially seeded at low density and grown to confluence before exposure to hormone. This correlated with the loss of most of the 10 to 15 mu diameter round cells. These observations suggest that preosteoclasts are present among these small cells that can give rise to osteoclasts upon treatment with PTH.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008795     DOI: 10.1016/8756-3282(86)90149-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Decreased oxidative stress and greater bone anabolism in the aged, when compared to the young, murine skeleton with parathyroid hormone administration.

Authors:  Robert L Jilka; Maria Almeida; Elena Ambrogini; Li Han; Paula K Roberson; Robert S Weinstein; Starros C Manolagas
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

3.  Interleukin-4 as a bone regulatory factor: effects on murine osteoblast-like cells.

Authors:  J A Riancho; J González-Marcías; J A Amado; J M Olmos; J L Fernández-Luna
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

4.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

5.  Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.

Authors:  Marilina Piemontese; Jinhu Xiong; Yuko Fujiwara; Jeff D Thostenson; Charles A O'Brien
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-26       Impact factor: 4.310

6.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Parathyroid hormone and lipopolysaccharide induce murine osteoblast-like cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor.

Authors:  M C Horowitz; D L Coleman; P M Flood; T S Kupper; R L Jilka
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

8.  Oxidation-specific epitopes restrain bone formation.

Authors:  Elena Ambrogini; Xuchu Que; Shuling Wang; Fumihiro Yamaguchi; Robert S Weinstein; Sotirios Tsimikas; Stavros C Manolagas; Joseph L Witztum; Robert L Jilka
Journal:  Nat Commun       Date:  2018-06-06       Impact factor: 14.919

9.  WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M.

Authors:  Petra Henning; Sofia Movérare-Skrtic; Anna Westerlund; Pedro Paulo Chaves de Souza; Thais Floriano-Marcelino; Karin H Nilsson; Maha El Shahawy; Claes Ohlsson; Ulf H Lerner
Journal:  J Inflamm Res       Date:  2021-09-18

10.  A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.

Authors:  Michela Palmieri; Ha-Neui Kim; Horacio Gomez-Acevedo; Xuchu Que; Sotirios Tsimikas; Robert L Jilka; Stavros C Manolagas; Joseph L Witztum; Elena Ambrogini
Journal:  J Bone Miner Res       Date:  2020-09-29       Impact factor: 6.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.